At MAPT locus (17q21.31) with extensive LD, we applied PGC analysis (Methods) integrating evidence across both DNE traits and disease endpoints, as xQTL and endpoint alone cannot resolve gene prioritization in such complex loci where 54 genes show xQTL-AD association evidence in our tiered genes. This evidence concerns the gene MAPT and Alzheimer disease.